2/4
11:36 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) had its price target raised by analysts at Cantor Fitzgerald from $6.00 to $10.00. They now have an "overweight" rating on the stock.
Low
Report
CytomX Therapeutics (NASDAQ:CTMX) had its price target raised by analysts at Cantor Fitzgerald from $6.00 to $10.00. They now have an "overweight" rating on the stock.
2/4
08:13 am
ctmx
CytomX Therapeutics to Present at Upcoming February Conferences [Yahoo! Finance]
Medium
Report
CytomX Therapeutics to Present at Upcoming February Conferences [Yahoo! Finance]
2/4
08:00 am
ctmx
CytomX Therapeutics to Present at Upcoming February Conferences
Medium
Report
CytomX Therapeutics to Present at Upcoming February Conferences
2/4
07:03 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) was given a new $10.00 price target on by analysts at Barclays PLC.
Medium
Report
CytomX Therapeutics (NASDAQ:CTMX) was given a new $10.00 price target on by analysts at Barclays PLC.
2/3
03:35 am
ctmx
CytomX Therapeutics (CTMX) Is Up 14.0% After Early Probody Colorectal Cancer Data Are Welcomed By Analysts – Has The Bull Case Changed? [Yahoo! Finance]
Low
Report
CytomX Therapeutics (CTMX) Is Up 14.0% After Early Probody Colorectal Cancer Data Are Welcomed By Analysts – Has The Bull Case Changed? [Yahoo! Finance]
2/2
09:44 am
ctmx
Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX) [Yahoo! Finance]
Medium
Report
Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX) [Yahoo! Finance]
1/21
03:49 pm
ctmx
Wareham Development Leases Full Floor at EmeryStation Research Campus to CytomX Therapeutics [Yahoo! Finance]
Low
Report
Wareham Development Leases Full Floor at EmeryStation Research Campus to CytomX Therapeutics [Yahoo! Finance]
1/21
08:39 am
ctmx
Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock? [Yahoo! Finance]
Low
Report
Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock? [Yahoo! Finance]
1/21
06:19 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Low
Report
CytomX Therapeutics (NASDAQ:CTMX) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
1/20
07:17 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
CytomX Therapeutics (NASDAQ:CTMX) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
1/20
07:17 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
CytomX Therapeutics (NASDAQ:CTMX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
1/20
07:17 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Low
Report
CytomX Therapeutics (NASDAQ:CTMX) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
1/8
08:00 am
ctmx
CytomX Therapeutics Announces Business Update and Company Milestones for 2026
Low
Report
CytomX Therapeutics Announces Business Update and Company Milestones for 2026
1/7
05:11 am
ctmx
Piper Sandler and H.C. Wainwright Stay Bullish on CytomX (CTMX) [Yahoo! Finance]
Medium
Report
Piper Sandler and H.C. Wainwright Stay Bullish on CytomX (CTMX) [Yahoo! Finance]
12/24
07:01 am
ctmx
CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade) [Seeking Alpha]
Medium
Report
CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade) [Seeking Alpha]
12/21
07:42 am
ctmx
Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress [Yahoo! Finance]
Low
Report
Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress [Yahoo! Finance]
12/15
01:48 am
ctmx
CytomX: Easiest Money May Have Been Made, Although Pipeline Remains Compelling [Seeking Alpha]
Low
Report
CytomX: Easiest Money May Have Been Made, Although Pipeline Remains Compelling [Seeking Alpha]
12/6
06:45 pm
ctmx
What Analysts Think Is Changing the CytomX Therapeutics Story After Recent Cancer Developments [Yahoo! Finance]
Medium
Report
What Analysts Think Is Changing the CytomX Therapeutics Story After Recent Cancer Developments [Yahoo! Finance]
11/25
09:08 am
ctmx
CytomX Therapeutics to Present at Upcoming December Investor Conferences [Yahoo! Finance]
Low
Report
CytomX Therapeutics to Present at Upcoming December Investor Conferences [Yahoo! Finance]
11/25
08:00 am
ctmx
CytomX Therapeutics to Present at Upcoming December Investor Conferences
Medium
Report
CytomX Therapeutics to Present at Upcoming December Investor Conferences
11/22
09:23 am
ctmx
Why Analysts Say the CytomX Story Is Evolving After Recent Clinical Momentum and Price Target Hike [Yahoo! Finance]
Low
Report
Why Analysts Say the CytomX Story Is Evolving After Recent Clinical Momentum and Price Target Hike [Yahoo! Finance]
11/18
09:43 am
ctmx
CytomX Therapeutics: Leaning Into The Hype, But What's Next? [Seeking Alpha]
Medium
Report
CytomX Therapeutics: Leaning Into The Hype, But What's Next? [Seeking Alpha]
11/13
08:00 am
ctmx
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
Medium
Report
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
11/11
08:09 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) had its price target raised by analysts at HC Wainwright from $5.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
CytomX Therapeutics (NASDAQ:CTMX) had its price target raised by analysts at HC Wainwright from $5.00 to $10.00. They now have a "buy" rating on the stock.